MedTrace Logo

PLDD With or Without Transforaminal Epidural Steroid Injection in Lumbar Disc Herniation

NCT07400068 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2026-02-10

No results posted yet for this study

Summary

This prospective observational study aims to evaluate the clinical outcomes of patients with single-level lumbar disc herniation who undergo routine percutaneous laser disc decompression (PLDD).

In routine clinical practice, some patients receive an additional transforaminal anterior epidural steroid injection during the same session without an extra puncture. This study will prospectively follow patients who receive PLDD alone and those who receive PLDD combined with epidural steroid injection.

Pain intensity, functional status, analgesic use, need for additional interventions, and complications will be assessed over time. The results may help to clarify whether adding epidural steroid injection to PLDD improves clinical outcomes in patients with lumbar disc herniation.

Conditions

  • Lumbar Disc Herniation
  • Lumbar Radiculopathy

Interventions

PROCEDURE

Percutaneous Laser Disc Decompression (PLDD)

Routine minimally invasive laser-based disc decompression performed under fluoroscopic guidance to reduce intradiscal pressure in patients with lumbar disc herniation.

PROCEDURE

Transforaminal Anterior Epidural Steroid Injection

Routine transforaminal anterior epidural injection of dexamethasone performed under fluoroscopic guidance following PLDD during the same session without additional puncture.

Sponsors & Collaborators

  • Mersin University

    lead OTHER

Principal Investigators

  • Mesut Bakır · Mersin University Faculty of Medicine, Pain Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2027-04-01
Completion
2027-09-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07400068 on ClinicalTrials.gov